Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TM30339 in obese subjects
NCT00746824Phase 2Terminated
- Sponsor
- 7TM Pharma
- Start
- Aug 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules, Modified Peptides, Native Peptides
01
Overview
Phase 2, randomised, double-blind trial of TM30339 in obesity, sponsored by 7TM Pharma. Started Aug 2008; status: terminated.
02
Drugs
TM30339
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00746824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746824.